Big Molecule Watch

ID: 1b83e026-2619-30fb-68c4

/

Claimed Record

/

Organization: Goodwin Procter

Biosimilar and Biologic Business Developments Update – Collaborations and Licensing Deals

Big Molecule Watch · January 15, 2020

Biosimilar and Biologic Updates in China: Bevacizumab, Etanercept, Tislezumab, Infliximab, Eculizumab, Adalimumab

Big Molecule Watch · January 13, 2020

Federal Circuit Affirms Biosimilar-Related IPR Appeals; Bevacizumab Injunction Appeal Progresses

Big Molecule Watch · January 10, 2020

Immunex and Samsung Bioepis Seek to Stay Etanercept Biosimilar Litigation (UPDATED)

Big Molecule Watch · January 9, 2020

DEAL WATCH: End-of-Year Biosimilar Agreements

Big Molecule Watch · January 6, 2020

Practice Areas

Intellectual Property

Jurisdictions